SEC Filings

Investor Contacts

Katherine A. Littrell, PhD, RN
Vice President, Investor Relations

Diane H. Schrick
Senior Director, Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filings

Filing date Form Description Filing Group View
S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML
SC 13G/A

An amendment to the SC 13G filing

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

3,4,5
View HTML
5

Annual filing director officer or owner of more than ten percent.

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML

Copyright Morningstar